NASDAQ | ETF
The fund invests at least 80% of its total assets in the securities of the underlying index.
The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, Genomics & Biotechnology Companies), as defined by Solactive AG, the provider of the underlying index.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 6.36% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 5.67% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 4.91% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 4.88% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 4.87% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 4.55% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.30% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 4.27% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 4.03% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 3.92% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 3.92% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.78% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 3.55% |
| RARE | Ultragenyx | Healthcare | Biotechnology | 3.34% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 3.20% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 3.19% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.83% |
| RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 2.79% |
| 1548 | Genscript Biotech Corp | Healthcare | Biotechnology | 2.63% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.35% |